Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA.

Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M Jr.

Nature. 2008 Jul 24;454(7203):523-7. doi: 10.1038/nature07106. Epub 2008 Jun 11.

2.

Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.

Kell A, Stoddard M, Li H, Marcotrigiano J, Shaw GM, Gale M Jr.

J Virol. 2015 Nov;89(21):11056-68. doi: 10.1128/JVI.01964-15. Epub 2015 Aug 26.

3.

Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I.

Schnell G, Loo YM, Marcotrigiano J, Gale M Jr.

PLoS Pathog. 2012;8(8):e1002839. doi: 10.1371/journal.ppat.1002839. Epub 2012 Aug 2.

4.

DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.

Grünvogel O, Esser-Nobis K, Reustle A, Schult P, Müller B, Metz P, Trippler M, Windisch MP, Frese M, Binder M, Fackler O, Bartenschlager R, Ruggieri A, Lohmann V.

J Virol. 2015 Oct;89(20):10548-68. doi: 10.1128/JVI.01297-15. Epub 2015 Aug 12.

5.

EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.

Zhu C, Xiao F, Hong J, Wang K, Liu X, Cai D, Fusco DN, Zhao L, Jeong SW, Brisac C, Chusri P, Schaefer EA, Zhao H, Peng LF, Lin W, Chung RT.

J Virol. 2015 Jul;89(13):6608-18. doi: 10.1128/JVI.00364-15. Epub 2015 Apr 15.

6.

RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP.

Malathi K, Saito T, Crochet N, Barton DJ, Gale M Jr, Silverman RH.

RNA. 2010 Nov;16(11):2108-19. doi: 10.1261/rna.2244210. Epub 2010 Sep 10.

7.

RNA PAMPs as Molecular Tools for Evaluating RIG-I Function in Innate Immunity.

Ireton RC, Wilkins C, Gale M Jr.

Methods Mol Biol. 2017;1656:119-129. doi: 10.1007/978-1-4939-7237-1_6.

PMID:
28808965
8.

[RIG-I mediated hepatic innate immune signaling that controls HCV infection].

Saito T, Gale M Jr.

Uirusu. 2008 Dec;58(2):105-15. Review. Japanese.

9.

Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.

Wang Y, Ye L, Wang X, Li J, Song L, Ho W.

Innate Immun. 2013;19(2):193-202. doi: 10.1177/1753425912460414. Epub 2012 Oct 11.

10.

Structural basis of RNA recognition and activation by innate immune receptor RIG-I.

Jiang F, Ramanathan A, Miller MT, Tang GQ, Gale M Jr, Patel SS, Marcotrigiano J.

Nature. 2011 Sep 25;479(7373):423-7. doi: 10.1038/nature10537.

11.

Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2.

Saito T, Hirai R, Loo YM, Owen D, Johnson CL, Sinha SC, Akira S, Fujita T, Gale M Jr.

Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):582-7. Epub 2006 Dec 26.

12.

Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I.

Xu J, Mercado-López X, Grier JT, Kim WK, Chun LF, Irvine EB, Del Toro Duany Y, Kell A, Hur S, Gale M Jr, Raj A, López CB.

MBio. 2015 Oct 6;6(5):e01265-15. doi: 10.1128/mBio.01265-15.

13.

Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity.

Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, García-Sastre A, Katze MG, Gale M Jr.

J Virol. 2008 Jan;82(1):335-45. Epub 2007 Oct 17.

14.

ARF-like protein 16 (ARL16) inhibits RIG-I by binding with its C-terminal domain in a GTP-dependent manner.

Yang YK, Qu H, Gao D, Di W, Chen HW, Guo X, Zhai ZH, Chen DY.

J Biol Chem. 2011 Mar 25;286(12):10568-80. doi: 10.1074/jbc.M110.206896. Epub 2011 Jan 13.

15.

Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists.

Chiang C, Beljanski V, Yin K, Olagnier D, Ben Yebdri F, Steel C, Goulet ML, DeFilippis VR, Streblow DN, Haddad EK, Trautmann L, Ross T, Lin R, Hiscott J.

J Virol. 2015 Aug;89(15):8011-25. doi: 10.1128/JVI.00845-15. Epub 2015 May 27.

16.

Hepatitis C virus NS3/4A protease blocks IL-28 production.

Ding Q, Huang B, Lu J, Liu YJ, Zhong J.

Eur J Immunol. 2012 Sep;42(9):2374-82. doi: 10.1002/eji.201242388.

17.

Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling.

Wies E, Wang MK, Maharaj NP, Chen K, Zhou S, Finberg RW, Gack MU.

Immunity. 2013 Mar 21;38(3):437-49. doi: 10.1016/j.immuni.2012.11.018. Epub 2013 Mar 14.

18.

PACT- and RIG-I-Dependent Activation of Type I Interferon Production by a Defective Interfering RNA Derived from Measles Virus Vaccine.

Ho TH, Kew C, Lui PY, Chan CP, Satoh T, Akira S, Jin DY, Kok KH.

J Virol. 2015 Nov 25;90(3):1557-68. doi: 10.1128/JVI.02161-15. Print 2016 Feb 1.

19.

RNA species generated in vaccinia virus infected cells activate cell type-specific MDA5 or RIG-I dependent interferon gene transcription and PKR dependent apoptosis.

Myskiw C, Arsenio J, Booy EP, Hammett C, Deschambault Y, Gibson SB, Cao J.

Virology. 2011 May 10;413(2):183-93. doi: 10.1016/j.virol.2011.01.034. Epub 2011 Feb 26.

20.

A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses.

Oshiumi H, Miyashita M, Matsumoto M, Seya T.

PLoS Pathog. 2013;9(8):e1003533. doi: 10.1371/journal.ppat.1003533. Epub 2013 Aug 8.

Supplemental Content

Support Center